How Many Adults with Private Health Insurance Could Use GLP-1 Drugs



More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3% of adults with employer coverageMore

Leave a Reply

Your email address will not be published. Required fields are marked *